| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824764 | Clinical Therapeutics | 2015 | 12 Pages |
Abstract
Bioequivalence of the FDCs of dapagliflozin/metformin XR and the ICs was established, and no safety issues of clinical concern were raised.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Ming MS, Xiaoni PhD, Dapeng PhD, Dan MS, Frank PhD, Steven C. MD, Susan MA, Donette MS, David W. PhD,